Cloudian Gaining Increased Market Traction in Healthcare and Life Sciences
February 11, 2019 08:00 ET
|
Cloudian
SAN MATEO, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cloudian, the innovation leader in enterprise object storage, today highlighted its expanding footprint in the healthcare and life sciences...
Megaputer Delivers Free Webinar Series on Pharma Analytics
February 05, 2019 09:00 ET
|
Megaputer Intelligence
BLOOMINGTON, Ind., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Megaputer Intelligence recently announced that it will host a series of live webinars related to data analysis applications for pharmaceutical...
Uptick Newswire Hosts Pressure BioSciences, Inc. on the Stock Day Podcast to Discuss Their (1) Just Announced Collaboration With NutraFuels, Inc., (2) the Commercial Launch of Their BioPharmaceuticals Contract Services Business, and (3) the Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018
February 04, 2019 08:13 ET
|
Pressure BioSciences, Inc.
PHOENIX, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of...
Customized Peptide Synthesis Market Size to Reach $390 Million by 2024: P&S Intelligence
January 24, 2019 01:45 ET
|
Prescient & Strategic Intelligence
Customized Peptide Synthesis Market by Product (Reagents, Equipment [Peptide Synthesizers, Chromatography Equipment, Lyophilizers]), by Application (Commercial [Antibody Production, Drug Discovery,...
Global Life Science Analytics Market to Witness a CAGR of 12.1% during 2018-2024
January 15, 2019 04:36 ET
|
Energias Market Research
NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Global Life Science Analytics market is expected to grow significantly from USD 10.6 billion in 2017 to USD 25.2 billion in 2024, at a CAGR of 12.1% from...
Mark Hensley Promoted to Chief Commercial Officer of Veloxis Pharmaceuticals
January 02, 2019 18:49 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 01/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 January 2019 Mark Hensley Promoted to Chief Commercial...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
December 30, 2018 22:23 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 24/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2018 Veloxis Pharmaceuticals A/S Grants Warrants...
Veloxis Pharmaceuticals Announces Financial Calendar for 2019
December 28, 2018 17:12 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 23/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 December 2018 Veloxis...
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
December 19, 2018 16:20 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 22/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 December 2018 FDA Approves New Indication for ENVARSUS XR®...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 18, 2018 17:53 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 21/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 18 December 2018 Veloxis Increases Share Capital in...